Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Engage Grants Program

University of British Columbia

$25,000.00

Traumatization of neurospheres for elicitation of tau aggregation in their constituent neurons

FY 2015-16

Summary
The treatment of neurodegenerative diseases such as Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE) and frontotemporal dementia (FTD) is an urgent national priority. However, there are no known therapies against these diseases. Drug discovery in this category has been stymied by the absence of reliable screening tools for evaluating the performance of drug candidates before they are tested on human patients in clinical trials. Specifically, the model systems employed by the pharmaceutical industry to screen drug candidates do not accurately recapitulate the microenvironment of a degenerated human brain. To this end, our research group at the University of British Columbia, in collaboration with scientists from STEMCELL Technologies Inc., proposes to apply principles and methodologies of tissue engineering to construct a faithful and accurate mimic a degenerated human brain for use as a drug screening platform. Specifically, the current proposal seeks to develop and validate a key step in the construction of the model organ - the elicitation of neurodegeneration in otherwise healthy brain tissue, and we will employ recent insights about biochemical similarities and dissimilarities between AD, CTE and FTD to achieve our goal. We anticipate that the current project will lay the foundations for the eventual development of an organoid biomanufacturing platform that will be integrated into the pharmaceutical industry's existing drug discovery infrastructure.
Program
Engage Grants Program
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
492049-2015
Name nom
Yadav, VikramadityaGanapati
Department département
Chemical and Biological Engineering
Organization id
2
Institution établissement
University of British Columbia
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2015
Competition year année de concours
2015
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Traumatization of neurospheres for elicitation of tau aggregation in their constituent neurons
Keyword
NSERC
Application summary
The treatment of neurodegenerative diseases such as Alzheimer's disease (AD), chronic traumatic encephalopathy (CTE) and frontotemporal dementia (FTD) is an urgent national priority. However, there are no known therapies against these diseases. Drug discovery in this category has been stymied by the absence of reliable screening tools for evaluating the performance of drug candidates before they are tested on human patients in clinical trials. Specifically, the model systems employed by the pharmaceutical industry to screen drug candidates do not accurately recapitulate the microenvironment of a degenerated human brain. To this end, our research group at the University of British Columbia, in collaboration with scientists from STEMCELL Technologies Inc., proposes to apply principles and methodologies of tissue engineering to construct a faithful and accurate mimic a degenerated human brain for use as a drug screening platform. Specifically, the current proposal seeks to develop and validate a key step in the construction of the model organ - the elicitation of neurodegeneration in otherwise healthy brain tissue, and we will employ recent insights about biochemical similarities and dissimilarities between AD, CTE and FTD to achieve our goal. We anticipate that the current project will lay the foundations for the eventual development of an organoid biomanufacturing platform that will be integrated into the pharmaceutical industry's existing drug discovery infrastructure.